Credit Suisse »

Travere Therapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $917k 102k 8.99
2023-09-30 $551k 62k 8.94
2023-06-30 $1.3M 87k 15.36
2023-03-31 $1.2M 54k 22.49
2022-12-31 $953k 45k 21.03
2022-09-30 $1.2M 47k 24.67
2022-06-30 $1.0M 42k 24.17
2022-03-31 $1.2M 45k 25.78
2021-12-31 $1.4M 46k 31.08
2021-09-30 $972k 40k 24.34
2021-06-30 $477k 33k 14.42
2021-03-31 $1.0M 36k 28.99
2020-12-31 $1.6M 61k 25.64